Skip Navigation


Schizophrenia Bulletin Advance Access originally published online on September 21, 2005
Schizophrenia Bulletin 2005 31(4):895-897; doi:10.1093/schbul/sbi067
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
31/4/895    most recent
sbi067v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Harvey, P. D
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Harvey, P. D
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2005. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center. All rights reserved. For permissions, please email: journals.permissions@oxfordjournals.org.

Conference Report: The Seventh Biennial Mt. Sinai Conference on Cognition in Schizophrenia

Philip D Harvey
Mt. Sinai School of Medicine

The first 150 words of the full text of this article appear below.

The Seventh Biennial Mt. Sinai Conference on Cognition in Schizophrenia was held on April 1 (afternoon) and April 2, 2005, at the Savannah International Trade and Conference Center. As it has been since 1999, this meeting was held as an official satellite of the International Congress on Schizophrenia Research (ICOSR). This meeting was attended by 295 individuals, for at least part of the meeting, making it the largest stand-alone meeting addressing cognition in schizophrenia.

The themes of the oral presentations at the meeting were consistent with two major trends in cognition in schizophrenia: a focus on treatment of cognitive deficits and a comprehensive approach to understanding the causes and functional relevance of cognitive deficits. In addition to the two sessions of oral presentations by high-level scientists, there was also a poster session, which featured 54 presentations. Of these poster presentations, 18 were also presented at a special cosponsored session at . . . [Full Text of this Article]


   Treatment of Cognitive Impairment: New Strategies and New Targets
 

   Memory in Schizophrenia: From Genes to Jobs
 

   Summary
 
To whom correspondence should be addressed; tel: 212-659-8713, fax: 212-860-3945, e-mail: philipdharvey1@cs.com.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Psychiatr. Serv.Home page
E. Bromley
Barriers to the Appropriate Clinical Use of Medications That Improve the Cognitive Deficits of Schizophrenia
Psychiatr Serv, April 1, 2007; 58(4): 475 - 481.
[Abstract] [Full Text] [PDF]